Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.
There are many non-surgical treatments for basal cell carcinomas, but a physician reporting at EADV last week said new treatments should be compared against surgery, which has the highest cure rate and lowest rate of recurrence.
Potential new treatment with targeted monoclonal antibodies offers new hope for cutaneous lymphoma patients.
As dermatologists become increasingly aware of comorbidities associated with psoriasis, questions of associated malignancy risk remain. Dr. Megan Noe emphasizes the need for skin cancer checks.
In this article, we review the American Academy of Dermatology treatment guidelines for cutaneous squamous cell carcinoma.
People who use indoor scanners may be putting themselves at greater risk for skin cancer because they use low SPF sunscreen.
Solid organ transplant recipients experience an average of two cutaneous squamous cell carcinomas following their transplant.
Two to three months of neoadjuvant topical imiquimod, 5%, cream prior to conservatively staged excisions for lentigo maligna (LM) is associated with a low rate of recurrence.
Chance of metastasis for cutaneous squamous cell carcinomas of vermillion lip is five times greater than on the cutaneous lip, study shows.
In this review article, Kaivon Sobhani, B.S., and, Eve Lowenstein, M.D., Ph.D., examine fibrotic skin lesions, including the cutaneous tumor dermatofibrosarcoma protuberan (DFSP).